Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Dapice Joshua J. reported a 9.90% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 11, 2025

Dapice Joshua J. reported a 9.90% stake in Enanta Pharmaceuticals, Inc., 2,108,262 shares, as a passive investor on Dec 31, 2024. Filed Feb 11, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
2,108,262
Intent
Passive
What changed
Stake changed
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.90%395,700
Farallon Capital Institutional Partners, L.P.2.20%464,400
Farallon Capital Institutional Partners II, L.P.0.50%108,700
Farallon Capital Institutional Partners III, L.P.0.30%58,500
Four Crossings Institutional Partners V, L.P.0.40%74,800
Farallon Capital Offshore Investors II, L.P.3.90%822,766
Farallon Capital (AM) Investors, L.P.0.20%42,200
Farallon Capital F5 Master I, L.P.0.70%141,196
Farallon Partners, L.L.C.9.30%1,967,066
Farallon Institutional (GP) V, L.L.C.0.40%74,800
Farallon F5 (GP), L.L.C.0.70%141,196
Dapice Joshua J.9.90%2,108,262
Dreyfuss, Philip D.9.90%2,108,262
Dunn Hannah E.9.90%2,108,262
Fried, Richard B9.90%2,108,262
Gehani, Varun N.9.90%2,108,262
Giauque, Nicolas9.90%2,108,262
Kim, David T.9.90%2,108,262
Linn, Michael G.9.90%2,108,262
Luo Patrick (Cheng)9.90%2,108,262
Patel, Rajiv A.9.90%2,108,262
Roberts, Jr., Thomas G.9.90%2,108,262
Saito Edric C.9.90%2,108,262
Seybold, William9.90%2,108,262
Short Daniel S.9.90%2,108,262
Spokes, Andrew J. M.9.90%2,108,262
Warren, John R.9.90%2,108,262
Wehrly, Mark C.9.90%2,108,262

Source

View original at SEC

Related